AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?

AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?

The cytoprotective effects of MK-801 and NBQX, selective N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor antagonists, respectively, were compared both singularly and in combination in models of transient severe forebrain and transient focal c...

Podrobná bibliografie
Hlavní autoři:	Buchan, A, Lesiuk, H, Barnes, K, Li, H, Huang, Z, Smith, K, Xue, D
Médium:	Journal article
Jazyk:	English
Vydáno:	1993

Podobné jednotky

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
Autor: Xue, D, a další
Vydáno: (1994)

DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION
Autor: Xue, D, a další
Vydáno: (1992)

POSTISCHEMIC TREATMENT WITH AMPA, BUT NOT NMDA, ANTAGONISTS PREVENTS CA1 NEURONAL INJURY
Autor: Li, H, a další
Vydáno: (1992)

The rise and fall of NMDA antagonists for ischemic stroke.
Autor: Hoyte, L, a další
Vydáno: (2004)

NMDA antagonists: their role in neuroprotection.
Autor: Small, D, a další
Vydáno: (1997)

NMDA antagonists: their role in neuroprotection.
Autor: Small, D, a další
Vydáno: (1997)

Do NMDA antagonists prevent neuronal injury? No.
Autor: Buchan, A
Vydáno: (1992)

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
Autor: Caitlyn J. Bartsch, a další
Vydáno: (2022-06-01)

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
Autor: Buchan, A, a další
Vydáno: (1992)

Neuroprotection, excitotoxicicity and nmda antagonists
Autor: RUBENS JOSÉ GAGLIARDI
Vydáno: (2000-06-01)

Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
Autor: Buchan, A
Vydáno: (1990)

INVERSE AGONISTS: MORE THAN JUST ANTAGONISTS?
Autor: R. N. Alyautdin, a další
Vydáno: (2022-06-01)

Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia.
Autor: Buchan, A, a další
Vydáno: (1991)

NMDA Receptor Antagonists for Treatment of Depression
Autor: Zeynep Ates-Alagoz, a další
Vydáno: (2013-04-01)

Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
Autor: Hicks, C, a další
Vydáno: (1999)

CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
Autor: Menniti, F, a další
Vydáno: (2003)

NEUROPROTECTIVE PROFILE OF FPL-15896AR, A NOVEL UNCOMPETITIVE NMDA ANTAGONIST
Autor: Murray, R, a další
Vydáno: (1995)

Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
Autor: Li, H, a další
Vydáno: (1993)

HYPOTHERMIA BUT NOT NMDA RECEPTOR ANTAGONIST MK-801 ATTENUATES NEURON DAMAGE - ARE THE RESULTS CONCLUSIVE - REPLY
Autor: Buchan, A, a další
Vydáno: (1992)

NMDA receptor antagonists in the treatment of neurological diseases
Autor: I. S. Preobrazhenskaya
Vydáno: (2020-10-01)

PSYCHOPHARMACOLOGICAL PROFILE OF THE NMDA RECEPTOR ANTAGONIST MK-801
Autor: Iversen, S, a další
Vydáno: (1987)

Cold Pain Threshold and Role of NMDA Receptor Antagonists
Autor: Poroshat Nazemi, a další
Vydáno: (2019-01-01)

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
Autor: Gregory R. Tintinger, a další
Vydáno: (2010-01-01)

NMDA receptor antagonists can enhance or impair learning performance in animals.
Autor: Mondadori, C, a další
Vydáno: (1989)

NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments
Autor: I.S. Preobrazhenskaya
Vydáno: (2014-10-01)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
Autor: Tetsuro Kikuchi
Vydáno: (2020-07-01)

NMDA receptor antagonists as potential therapy in cerebellar degenerative disorders
Autor: Olga S. Belozor, a další
Vydáno: (2022-06-01)

Modulation of functional EEG networks by the NMDA antagonist nitrous oxide.
Autor: Levin Kuhlmann, a další
Vydáno: (2013-01-01)

NMDA receptor antagonist ketamine impairs feature integration in visual perception.
Autor: Julia D I Meuwese, a další
Vydáno: (2013-01-01)

Agonist hold Antagonist Protocol versus Antagonist Protocol in Intracytoplasmic Sperm Injection for Infertile Patients with Polycystic Ovary Syndrome
Autor: Hazem H. Ahmed, a další
Vydáno: (2022-01-01)

Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia
Autor: A. P. Pereverzev, a další
Vydáno: (2019-12-01)

Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice
Autor: Naser Osanloo, a další
Vydáno: (2015-10-01)

NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury.
Autor: Yang Li, a další
Vydáno: (2015-01-01)

Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain.
Autor: Carla M Yuede, a další
Vydáno: (2010-06-01)

NMDA-receptor antagonists disrupt the formation of the auditory space map in the mammalian superior colliculus.
Autor: Schnupp, J, a další
Vydáno: (1995)

Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemia
Autor: Gary K. Steinberg, a další
Vydáno: (1995-04-01)

Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
Autor: F. A. Zeiler
Vydáno: (2015-01-01)

NMDA Receptor Antagonist Memantine Ameliorates Experimental Autoimmune Encephalomyelitis in Aged Rats
Autor: Biljana Bufan, a další
Vydáno: (2024-03-01)

NMDA Receptor-Antagonistic Properties of Hyperforin, a Constituent of St. John’s Wort
Autor: Vikas Kumar, a další
Vydáno: (2006-01-01)

Ammonia-mediated LTP inhibition: Effects of NMDA receptor antagonists and l-carnitine
Autor: Yukitoshi Izumi, a další
Vydáno: (2005-11-01)